|
Nutraceuticals
for Animals |
|
|
|
|
|
|
|
Human health starts with the food on which it survives. It is therefore of paramount importance that the farm animals we eat should be healthy and of the highest quality.
IMBT will provide a range of insect
nutraceuticals that enhance animal health, through
the provision of a range of naturally produced vitamins,
unsaturated fatty acids, protein, trace elements
and antimicrobial peptides. In chickens the insect
feed will help eliminate feather pecking, as the
innate predisposition to peck and be rewarded is
satisfied! The nutraceuticals will boost
protection against fungal, viral, bacterial and parasitic
diseases.
|
|
Nutraceuticals for People |
|
|
|
|
|
|
|
To
provide the 'immune vitamins` that are lacking in
many intensively produced foods , IMBT will produce
a range of insect based nutraceuticals / functional
foods that boost human immune systems and assist
the body in its fight and defense against fungal,
viral, bacterial and parasitic diseases and the ills
that accompany them.
|
|
Antibiotics |
|
|
|
|
|
|
|
IMBT
will provide an alternative to current antibiotics
with its new range of insect-sourced AMPs.
|
|
Vaccines |
|
|
|
|
|
|
|
IMBT
will produce a new range of vaccines that inactivate
the pathogen with AMPs but still leaves it capable
of inducing a long-term memory adaptive immune
response, and that does not involve the presentation
of live vaccines to potentially immuno-compromised
individuals. IMBT technology does not involve
genetic manipulation.
|
|
Wound Therapy |
|
|
|
|
|
|
|
IMBT will provide a range of wound dressings that incorporate an array of antimicrobial peptides that keep the wound clean of infection, recruit host lymphocytes and repair cells to the injury and assist the recovery process.
|
|
|
Fertilizers |
|
|
|
|
|
|
|
IMBT
will provide a range of fertilizers that give slow
release nitrogen,whilst
enhancing root growth development and plant health,
improve soil structure
and assist in water soil retention.
|
|
Strategic Advantages |
|
|
|
|
|
|
|
The technology is environmentally benign.
It does not incorporate GM technology.
It does not lead to bacterial resistance.
It supplements the host's immune
system and does not compromise it as with TNFα blockers.
It offers sustainable solutions for healthcare and
the management and recycling of biological waste.
Unlike
conventional antibiotics , AMPs do not cause
septic shock. AMPs are not indiscriminate and do
not destroy natural gut bacterial fauna.
|
|
Home | Science | Technology | Sustainability
| Products | Collaboration | Contact
Us |
|